Ignite Creation Date:
2025-12-25 @ 3:48 AM
Ignite Modification Date:
2025-12-26 @ 2:35 AM
Study NCT ID:
NCT00132002
Status:
TERMINATED
Last Update Posted:
2015-03-19
First Post:
2005-08-16
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Suberoylanilide Hydroxamic Acid in Treating Patients With Progressive Stage IV Breast Cancer
Sponsor:
National Cancer Institute (NCI)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2005-06
Start Date Type:
None
Primary Completion Date:
2008-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2008-01
Completion Date Type:
ACTUAL
First Submit Date:
2005-08-16
First Submit QC Date:
None
Study First Post Date:
2005-08-19
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2015-03-06
Results First Submit QC Date:
None
Results First Post Date:
2015-03-19
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2015-03-06
Last Update Post Date:
2015-03-19
Last Update Post Date Type:
ESTIMATED